Overview
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea (Orphanet code 238763) is a rare inherited ocular disorder characterized by the combination of an abnormally spherical lens (spherophakia), displacement of the lens from its normal position (ectopia lentis), and an enlarged cornea (megalocornea), which together predispose the eye to the development of secondary glaucoma. The condition primarily affects the anterior segment of the eye. Spherophakia causes the lens to become more rounded and smaller than normal, which can lead to pupillary block as the abnormal lens pushes forward, obstructing the flow of aqueous humor between the posterior and anterior chambers. This obstruction results in elevated intraocular pressure and secondary angle-closure glaucoma. Megalocornea, defined as a corneal diameter greater than 13 mm, further contributes to structural abnormalities of the anterior chamber. Ectopia lentis may cause visual disturbances including significant refractive errors and can worsen the mechanical obstruction of aqueous outflow. Patients typically present with decreased visual acuity, eye pain, and progressive visual field loss if glaucoma is not adequately managed. The condition may occur as an isolated ocular finding or in association with systemic connective tissue disorders such as Marfan syndrome, Weill-Marchesani syndrome, or homocystinuria, where lens abnormalities are a recognized feature. Diagnosis is made through comprehensive ophthalmic examination including slit-lamp biomicroscopy, gonioscopy, measurement of intraocular pressure, and assessment of corneal diameter. Treatment focuses on controlling intraocular pressure through medical therapy (topical and systemic anti-glaucoma medications, including miotics or cycloplegics depending on the mechanism), laser iridotomy to relieve pupillary block, and surgical intervention when necessary, which may include lensectomy (removal of the displaced lens), glaucoma filtering surgery, or combined procedures. Early detection and management are critical to prevent irreversible optic nerve damage and vision loss.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Glaucoma secondary to spherophakia/ectopia lentis and megalocornea.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Glaucoma secondary to spherophakia/ectopia lentis and megalocornea at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Glaucoma secondary to spherophakia/ectopia lentis and megalocornea.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Glaucoma secondary to spherophakia/ectopia lentis and megalocornea.
Community
No community posts yet. Be the first to share your experience with Glaucoma secondary to spherophakia/ectopia lentis and megalocornea.
Start the conversation →Latest news about Glaucoma secondary to spherophakia/ectopia lentis and megalocornea
No recent news articles for Glaucoma secondary to spherophakia/ectopia lentis and megalocornea.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Glaucoma secondary to spherophakia/ectopia lentis and megalocornea
What is Glaucoma secondary to spherophakia/ectopia lentis and megalocornea?
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea (Orphanet code 238763) is a rare inherited ocular disorder characterized by the combination of an abnormally spherical lens (spherophakia), displacement of the lens from its normal position (ectopia lentis), and an enlarged cornea (megalocornea), which together predispose the eye to the development of secondary glaucoma. The condition primarily affects the anterior segment of the eye. Spherophakia causes the lens to become more rounded and smaller than normal, which can lead to pupillary block as the abnormal lens pushes forwar